Researchers at Uppsala University and KTH Royal Institute of Technology have created an antibody that has the potential to treat a variety of cancers. Read further on Dynamite News:
The study, published in the British Journal of Cancer, examined how RRM affects the rate of death of women with a pathogenic variant but no cancer diagnosis. Read further on Dynamite News:
A recent study from Australian and Dutch experts revealed that older patients with kidney tumours who are not candidates for surgery may benefit from targeted, high-dose radiation. Read further on Dynamite News:
According to a new study, therapeutic hypothermia, the sole evidence-based treatment for neonates born with neonatal encephalopathy (NE) at or after 36 weeks, is ineffective for lowering death or moderate/severe damage in newborns born between 33 and 35 weeks. Read further on Dynamite News:
The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of Covaxin COVID-19 vaccine for the 2-18 age group.
English
English
English
